Increased prevalence of intestinal inflammation in patients with liver cirrhosis

World Journal of Gastroenterology

Volumn 5, Issue 5, 1999, Pages 391-396

  Saitoh, Osamu ^a   Sugi, Kazunori ^a   Kojima, Keishi ^a   Matsumoto, Hisashi ^b   Nakagawa, Ken ^a   Kayazawa, Masanobu ^a   Tanaka, Seigou ^a   Teranishi, Tsutomu ^a   Hirata, Ichiro ^a   Katsu, Ken Ichi ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b Ijinkai Takeda General Hospital   (Japan)

Author keywords

Fecal proteins; Inflammation; Intestinal; Liver cirrhosis; Secretory IgA

Indexed keywords

EID: 0000739895     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v5.i5.391     Document Type: Article

References (25)

1. McCormack TT, Sims J, Eyre-Brook I, Kennedy H, Goepel J, Johnson AG, Triger DR. Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy? Gut, 1985;26:1226 -1232
2. Iwao T, Toyonaga A, Sumino M, Takagi K, Oho K, Nishizono M, Ohkubo K, Inoue R, Sasaki E, Tanikawa K. Portal hypertensive gastropathy in patients with cirrhosis. Gastroenterology, 1992; 102: 2060-2065
3. Kozarek RA, Botoman VA, Bredfeldt JE, Roach JM, Patterson DJ, Ball TJ. Portal colopathy: prospective study of colonoscopy in patients with portal hypertension. Gastroenterology, 1991;101:1192-1197
4. Naveau S, Bedossa P, Poynard T, Mory B, Chaput JC. Portal hypertensive colopathy. A new entity. Dig Dis Sci, 1991;36:1774-1781
5. Losowsky MS, Walker BE. Liver disease and malabsorption. Gastroenterology, 1969;56:589-600
6. Romiti A, Merli M, Martorano M, Parrilli G, Martino F, Riggio O, Trusscelli A, Capocaccia L, Budillon G. Malabsorption and nutritional abnormalities in patients with liver cirrhosis. Ital J Gastroenterol, 1990;22:118-123
7. Iber FL. Protein loss into the gastrointestinal tract in cirrhosis of the liver. Am J Clin Nutr, 1966;19:219-222
8. Conn HO. Is protein-losing enteropathy a significant complication of portal hypertension? Am J Gastroenterol, 1998;93:127-128
9. Sugi K, Saitoh O, Nakagawa K, Sugimori K, Takada K, Yoshizumi M, Miyoshi H, Hirata I, Ohshiba S, Matsumoto H, Matsuse R, Uchida K. Fecal secretory IgA levels in patients with colorectal diseases. Digestion and Absorption, 1993;16:28-33
10. Saitoh O, Matsumoto H, Sugimori K, Sugi K, Nakagawa K, Miyoshi H, Hirata I, Matsuse R, Uchida K, Ohshiba S. Intestinal protein loss and bleeding assessed by fecal hemoglobin, transferrin, albumin, and alpha-1-antitrypsin levels in patients with colorectal diseases. Digestion, 1995;56:67-75
11. Saitoh O, Sugi K, Matsuse R, Uchida K, Matsumoto H, Nakagawa K, Takada K, Yoshizumi M, Hirata I, Katsu K. The forms and the levels of fecal PMN-elastase in patients with colorectal diseases. Am J Gastroenterol, 1995;90:388-393
12. Sugi K, Saitoh, Hirata I, Katsu K. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins. Am J Gastroenterol, 1996;91:927-934
13. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the esophagus for bleeding esophageal varices. Br J Surg, 1973;60:646-649
14. Stanley AJ, Gilmour HM, Ghosh S, Ferguson A, McGilchrist AJ. Transjugular intrahepatic portosystemic shunt as a treatment for protein-losing enteropathy caused by portal hypertension. Gastroenterology, 1996;111:1679-1682
15. Rabinovitz M, Schade RR, Dindzans VJ, Belle SH, van Thiel DH, Gavaler JS. Colonic disease in cirrhosis. An endoscopic evaluation in 412 patients. Gastroenterology, 1990;99:195-199
16. Scandalis N, Archimandritis A, Kastanas K, Spiliadis C, Delis B, Manika Z. Colonic findings in cirrhotics with portal hypertension. A prospective colonoscopic and histological study. J Clin Gastroenterol, 1994;18:325-329
17. Tam TN, Ng WW, Lee SD. Colonie mucosal changes in patients with liver cirrhosis. Gastrointest Endosc, 1995;42:408-412
18. Bresci G, Gambardella L, Parisi G, Federici G, Bertini M, Rindi G, Metrangolo S, Tumino E, Bertoni M, Cagno MC, Capria A. Colonic disease in cirrhotic patients with portal hypertension. An endoscopic and clinical evaluation. J Clin Gastroenterol, 1998;26:222-227
19. Pelletier G, Briantais MJ, Buffet C, Pillot J, Etienne JP. Serum and intestinal secretory IgA in alcoholic cirrhosis of the liver. Gut, 1982; 23:475-480
20. Quigley EMM. Gastrointestinal dysfunction in liver disease and portal hypertension. Gut-liver interactions revisited. Dig Dis Sci, 1996;41: 557-563
21. Saitoh O, Nakagawa K, Sugi K, Matsuse R, Uchida K, Kojima K, Tanaka S, Teranishi T, Hirata I, Katsu K. Bile acids inhibit tumor necrosis factor-α-induced interleukin-8 production in human colon epithelial cells. J Gastroenterol Hepatol, 1998;13:1212-1217
22. Vlahcevic R, Juttijudata P, Bell CCJr, Swell L. Bile acid metabolism in patients with cirrhosis. II. Cholic and chenodeoxycholic acid metabolism. Gastroenterology, 1972;62:1174-1181
23. Jönsson G, Hedenborg G, Wisen O, Norman A. Presence of bile acid metabolites in serum, urine, and feces in cirrhosis. Scand J Clin Invest, 1992;52:555-564
24. Laffineur G, Lescut D, Vincent P, Quandalle P, Wurtz A, Colombel JF. Bacterial translocation in Crohn disease. Gastroenterol Clin Biol, 1992;16:777-781
25. Saitoh O, Nakagawa K, Sugi K, Kojima K, Teranishi T, Tanaka S, Kayazawa M, MaemuraK, Hirata I, Katsu K. Plasma endotoxin level as a marker of disrupted intestinal mucosal barrier in inflammatory bowel disease. Bull Osaka Med Coll, 1997;43:95-101